PS
GILD icon

PayPay Securities’s Gilead Sciences GILD Stock Holding History

PayPay Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91K Hold
23
– – 0.07% 142
2026
Q1 		$3.19K Sell
23
-6
-21% -$840 0.11% 139
2025
Q4 		$3.56K Buy
29
+5
+21% +$608 0.1% 140
2025
Q3 		$2.61K Buy
24
+3
+14% +$341 0.09% 146
2025
Q2 		$2.33K Buy
21
+1
+5% +$106 0.11% 129
2025
Q1 		$2.33K Sell
20
-26
-57% -$2.68K 0.13% 145
2024
Q4 		$4.25K Buy
46
+12
+35% +$1.08K 0.18% 92
2024
Q3 		$2.85K Sell
34
-28
-45% -$2.14K 0.25% 80
2024
Q2 		$4.25K Sell
62
-1
-2% -$67 0.36% 74
2024
Q1 		$4.62K Buy
63
+3
+5% +$231 0.23% 91
2023
Q4 		$4.92K Buy
60
+10
+20% +$778 0.24% 90
2023
Q3 		$3.75K Buy
50
+1
+2% +$77 0.17% 110
2023
Q2 		$3.78K Sell
49
-21
-30% -$1.68K 0.23% 63
2023
Q1 		$5.81K Sell
70
-26
-27% -$2.15K 0.39% 43
2022
Q4 		$8.24K Buy
+96
New +$7.6K 0.55% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PayPay Securities's GILD Position: Q2 2026 in Review

PayPay Securities held its Gilead Sciences (GILD) position steady in Q2 2026 at 23 shares worth $2.91K. The position accounts for 0.07% of the portfolio, ranked #142.

PayPay Securities first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.24K in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PayPay Securities held 23 shares of Gilead Sciences worth $2.91K as of Q2 2026.
  • PayPay Securities left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.07% of PayPay Securities's portfolio in Q2 2026, its #142 holding.
  • PayPay Securities first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Gilead Sciences position peaked at $8.24K in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.